Balchem Corporation (BCPC) is set to report its Q4 2024 earnings on February 21, 2025. Analysts expect a significant increase in earnings per share (EPS) to $1.11, representing a 35.37% year-over-year growth. This positive outlook, combined with strong historical performance, suggests upward momentum for the stock.
BCPC is a key holding in the Fidelity Enhanced Large Cap Core ETF (FELC), with an analyst target price of $207.33, indicating a 23.62% upside from its current price of $167.72. This reflects strong analyst confidence in the stock's growth potential.
In Q4 2024, Balchem reported record sales of $240 million, a 4.9% year-over-year increase, with net income rising 26% to $34 million. The company also reduced its net debt to $140 million, demonstrating strong financial health and positioning it well for 2025 growth.
The stock is currently trading at $164.18, with a bullish trend indicated by its position above key moving averages (SMA-5: $164.81, SMA-10: $166.56). The MACD crossover also signals a buy opportunity, with the stock price testing the upper Bollinger Band.
The Fibonacci resistance levels suggest a near-term target of $173.87 (R1) and $177.70 (R2), with support at $161.48 (S1).
Based on strong earnings expectations, positive ETF analyst targets, and bullish technical indicators, the stock is expected to rise to $173.87 in the next trading week. This represents a buy opportunity.
The price of BCPC is predicted to go up -3.64%, based on the high correlation periods with SSL. The similarity of these two price pattern on the periods is 95.56%.
BCPC
SSL